Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MDGL

Madrigal Pharmaceuticals Inc

May 27 • 04:00PM ET

527.67

+3.39 0.65 %

Healthcare • Biotechnology • USA • Large • NASD

Peers: BBIO VKTX BMRN EXEL INCY KRYS ALNY RARE REGN VRTX

| Held by: VTI VB IWM VBK XBI VXF IBB IWO SCHA VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-12.80	Insider Own	8.69%	Shs Outstand	23.04M	Perf Week	3.10%
Market Cap	12.17B	Forward P/E	50.06	EPS next Y	10.54	Insider Trans	-5.30%	Shs Float	21.06M	Perf Month	1.46%
Enterprise Value	11.70B	PEG	-	EPS next Q	-2.38	Inst Own	105.18%	Short Float	18.30%	Perf Quarter	21.30%
Income	-309.44M	P/S	10.74	EPS this Y	49.05%	Inst Trans	2.78%	Short Ratio	12.07	Perf Half Y	-3.70%
Sales	1.13B	P/B	22.37	EPS next Y	260.99%	ROA	-27.83%	Short Interest	3.85M	Perf YTD	-9.39%
Book/sh	23.59	P/C	14.87	EPS next 5Y	-	ROE	-49.35%	52W High	615.00 -14.20%	Perf Year	94.30%
Cash/sh	35.48	P/FCF	-	EPS past 3/5Y	9.32% 0.37%	ROIC	-34.80%	52W Low	265.00 99.12%	Perf 3Y	85.23%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	92.94%	Volatility	3.55% 4.15%	Perf 5Y	371.09%
Dividend TTM	-	EV/Sales	10.33	EPS Y/Y TTM	29.06%	Oper. Margin	-27.68%	ATR (14)	20.93	Perf 10Y	4070.48%
Dividend Ex-Date	-	Quick Ratio	3.16	Sales Y/Y TTM	256.82%	Profit Margin	-27.32%	RSI (14)	54.84	Recom	1.28
Dividend Gr. 3/5Y	- -	Current Ratio	3.50	EPS Q/Q	1.93%	SMA20	1.71%	Beta	-1.06	Target Price	679.33
Payout	-	Debt/Eq	0.64	Sales Q/Q	126.84%	SMA50	3.33%	Rel Volume	0.45	Prev Close	524.28
Employees	915	LT Debt/Eq	0.64	Earnings	May 06 BMO	SMA200	8.50%	Avg Volume	319.29K	Price	527.67
IPO	Feb 06, 2007	Option/Short	Yes / Yes	EPS/Sales Surpr.	23.16% 3.42%	Trades		Volume	144,040	Change	0.65%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)